Clinical trial
Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney…
NCT00126659 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00126659 |
|---|---|
| Title | Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer |
| Official title | A Phase II Neoadjuvant Clinical Trial to Evaluate the Efficacy of BAY 43-9006 (Sorafenib) in Metastatic Renal Cell Carcinoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | therapeutic conventional surgery, sorafenib tosylate, laboratory biomarker analysis |
| Enrollment | 10 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Aug 4, 2005 |
| Last update posted | Nov 20, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: